Literature DB >> 11682605

UV-induced binding of ING1 to PCNA regulates the induction of apoptosis.

M Scott1, P Bonnefin, D Vieyra, F M Boisvert, D Young, D P Bazett-Jones, K Riabowol.   

Abstract

Previous studies have shown that UV-induced binding of p21(WAF1) to PCNA through the PCNA-interacting protein (PIP) domain in p21(WAF1) promotes a switch from DNA replication to DNA repair by altering the PCNA protein complex. Here we show that the p33(ING1b) isoform of the ING1 candidate tumour suppressor contains a PIP domain. UV rapidly induces p33(ING1b) to bind PCNA competitively through this domain, a motif also found in DNA ligase, the DNA repair-associated FEN1 and XPG exo/endonucleases, and DNA methyltransferase. Interaction of p33(ING1b) with PCNA occurs between a significant proportion of ING1 and PCNA, increases more than tenfold in response to UV and is specifically inhibited by overexpression of p21(WAF1), but not by p16(MTS1), which has no PIP sequence. In contrast to wild-type p33(ING1b), ING1 PIP mutants that do not bind PCNA do not induce apoptosis, but protect cells from UV-induced apoptosis, suggesting a role for this PCNA-p33(ING1b) interaction in eliminating UV-damaged cells through programmed cell death. These data indicate that ING1 competitively binds PCNA through a site used by growth regulatory and DNA damage proteins, and may contribute to regulating the switch from DNA replication to DNA repair by altering the composition of the PCNA protein complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682605     DOI: 10.1242/jcs.114.19.3455

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  53 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  Molecular cloning and expression analysis of inhibitor of growth protein 3 (ING3) in the Manila clam, Ruditapes philippinarum.

Authors:  Guang-Wei Hu; Xi-Wu Yan; Yan-Jie Qin; Hong-Tao Nie
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

3.  NuA4 subunit Yng2 function in intra-S-phase DNA damage response.

Authors:  John S Choy; Stephen J Kron
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.

Authors:  Ute Gesche Tallen; Matthias Truss; Frank Kunitz; Sven Wellmann; Brad Unryn; Brigitte Sinn; Ulrike Lass; Sonja Krabbe; Nikola Holtkamp; Christian Hagemeier; Reinhard Wurm; Guenter Henze; Karl T Riabowol; Andreas von Deimling
Journal:  J Neurooncol       Date:  2007-09-01       Impact factor: 4.130

5.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 6.  The role of the tumour suppressor p33 ING1b in human neoplasia.

Authors:  G S Nouman; J J Anderson; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

7.  Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Authors:  Julieta M Ceruti; María F Ogara; Camino Menéndez; Ignacio Palmero; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2013-03-04       Impact factor: 3.396

8.  NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b).

Authors:  Marco Garate; Ronald P C Wong; Eric I Campos; Yemin Wang; Gang Li
Journal:  EMBO Rep       Date:  2008-04-04       Impact factor: 8.807

Review 9.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

10.  REAP: A two minute cell fractionation method.

Authors:  Keiko Suzuki; Pinaki Bose; Rebecca Yy Leong-Quong; Donald J Fujita; Karl Riabowol
Journal:  BMC Res Notes       Date:  2010-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.